These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 18536860)
1. Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD. Johansson G; Lindberg A; Romberg K; Nordström L; Gerken F; Roquet A Prim Care Respir J; 2008 Sep; 17(3):169-75. PubMed ID: 18536860 [TBL] [Abstract][Full Text] [Related]
2. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ; Keating GM Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [TBL] [Abstract][Full Text] [Related]
3. Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial. Troosters T; Sciurba FC; Decramer M; Siafakas NM; Klioze SS; Sutradhar SC; Weisman IM; Yunis C NPJ Prim Care Respir Med; 2014 May; 24():14003. PubMed ID: 24841833 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study. Beier J; Kirsten AM; Mróz R; Segarra R; Chuecos F; Caracta C; Gil EG COPD; 2013 Aug; 10(4):511-22. PubMed ID: 23819698 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N; Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228 [TBL] [Abstract][Full Text] [Related]
6. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677 [TBL] [Abstract][Full Text] [Related]
7. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance. Ambrosino N; Foglio K; Balzano G; Paggiaro PL; Lessi P; Kesten S; Int J Chron Obstruct Pulmon Dis; 2008; 3(4):771-80. PubMed ID: 19281092 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study. Buhl R; Gessner C; Schuermann W; Foerster K; Sieder C; Hiltl S; Korn S Thorax; 2015 Apr; 70(4):311-9. PubMed ID: 25677679 [TBL] [Abstract][Full Text] [Related]
9. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study. Bateman ED; van Dyk M; Sagriotis A Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684 [TBL] [Abstract][Full Text] [Related]
10. Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease. Zhou Y; Zhong NS; Li X; Chen S; Zheng J; Zhao D; Yao W; Zhi R; Wei L; He B; Zhang X; Yang C; Li Y; Li F; Du J; Gui J; Hu B; Bai C; Huang P; Chen G; Xu Y; Wang C; Liang B; Li Y; Hu G; Tan H; Ye X; Ma X; Chen Y; Hu X; Tian J; Zhu X; Shi Z; Du X; Li M; Liu S; Yu R; Zhao J; Ma Q; Xie C; Li X; Chen T; Lin Y; Zeng L; Ye C; Ye W; Luo X; Zeng L; Yu S; Guan WJ; Ran P N Engl J Med; 2017 Sep; 377(10):923-935. PubMed ID: 28877027 [TBL] [Abstract][Full Text] [Related]
11. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [TBL] [Abstract][Full Text] [Related]
12. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
13. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S Thorax; 2003 May; 58(5):399-404. PubMed ID: 12728159 [TBL] [Abstract][Full Text] [Related]
14. Tiotropium and simplified detection of dynamic hyperinflation. Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD. Abrahams R; Moroni-Zentgraf P; Ramsdell J; Schmidt H; Joseph E; Karpel J Respir Med; 2013 Jun; 107(6):854-62. PubMed ID: 23490224 [TBL] [Abstract][Full Text] [Related]
17. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Calverley PM; Lee A; Towse L; van Noord J; Witek TJ; Kelsen S Thorax; 2003 Oct; 58(10):855-60. PubMed ID: 14514937 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD. Fuhr R; Magnussen H; Sarem K; Llovera AR; Kirsten AM; Falqués M; Caracta CF; Garcia Gil E Chest; 2012 Mar; 141(3):745-752. PubMed ID: 21903737 [TBL] [Abstract][Full Text] [Related]
20. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Celli B; ZuWallack R; Wang S; Kesten S Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]